These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 8671651

  • 21. Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody.
    Chung DH, Belyakov IM, Derby MA, Wang J, Boyd LF, Berzofsky JA, Margulies DH.
    J Immunol; 2001 Jul 15; 167(2):699-707. PubMed ID: 11441073
    [Abstract] [Full Text] [Related]

  • 22. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
    Bergmann CC, Tong L, Cua RV, Sensintaffar JL, Stohlman SA.
    J Immunol; 1994 Jun 15; 152(12):5603-12. PubMed ID: 7515908
    [Abstract] [Full Text] [Related]

  • 23. Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice.
    Kuribayashi H, Wakabayashi A, Shimizu M, Kaneko H, Norose Y, Nakagawa Y, Wang J, Kumagai Y, Margulies DH, Takahashi H.
    Biochem Biophys Res Commun; 2004 Apr 02; 316(2):356-63. PubMed ID: 15020225
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.
    Kiszka I, Kmieciak D, Gzyl J, Naito T, Bolesta E, Sieron A, Singh SP, Srinivasan A, Trinchieri G, Kaneko Y, Kozbor D.
    J Virol; 2002 May 02; 76(9):4222-32. PubMed ID: 11932387
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.
    Johnson RP, Trocha A, Buchanan TM, Walker BD.
    J Exp Med; 1992 Apr 01; 175(4):961-71. PubMed ID: 1372650
    [Abstract] [Full Text] [Related]

  • 29. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV.
    J Immunol; 1993 May 15; 150(10):4659-71. PubMed ID: 7683326
    [Abstract] [Full Text] [Related]

  • 30. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.
    Wang Z, Turner R, Baker BM, Biddison WE.
    J Immunol; 2002 Sep 15; 169(6):3146-54. PubMed ID: 12218132
    [Abstract] [Full Text] [Related]

  • 31. Stimulation of human cytotoxic T cells with HIV-1-derived peptides presented by recombinant HLA-A2 peptide complexes.
    Walter JB, Brander C, Mammen M, Garboczi DN, Kalams SA, Whitesides GM, Walker BD, Eisen HN.
    Int Immunol; 1997 Mar 15; 9(3):451-9. PubMed ID: 9088983
    [Abstract] [Full Text] [Related]

  • 32. Molecular analysis of TCR and peptide/MHC interaction using P18-I10-derived peptides with a single D-amino acid substitution.
    Nakagawa Y, Kikuchi H, Takahashi H.
    Biophys J; 2007 Apr 01; 92(7):2570-82. PubMed ID: 17208967
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove.
    Shimojo N, Anderson RW, Mattson DH, Turner RV, Coligan JE, Biddison WE.
    Int Immunol; 1990 Apr 01; 2(3):193-200. PubMed ID: 2088485
    [Abstract] [Full Text] [Related]

  • 36. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens.
    Schirmbeck R, Deml L, Melber K, Wolf H, Wagner R, Reimann J.
    Vaccine; 1995 Jun 01; 13(9):857-65. PubMed ID: 7483809
    [Abstract] [Full Text] [Related]

  • 37. Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?
    Takahashi H, Nakagawa Y, Leggatt GR, Ishida Y, Saito T, Yokomuro K, Berzofsky JA.
    J Exp Med; 1996 Mar 01; 183(3):879-89. PubMed ID: 8642292
    [Abstract] [Full Text] [Related]

  • 38. Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1.
    Casement KS, Nehete PN, Arlinghaus RB, Sastry KJ.
    Virology; 1995 Aug 01; 211(1):261-7. PubMed ID: 7645219
    [Abstract] [Full Text] [Related]

  • 39. HLA-binding regions of HIV-1 proteins. II. A systematic study of viral proteins.
    Choppin J, Martinon F, Connan F, Pauchard M, Gomard E, Levy JP.
    J Immunol; 1991 Jul 15; 147(2):575-83. PubMed ID: 1712812
    [Abstract] [Full Text] [Related]

  • 40. Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes.
    Chada S, DeJesus CE, Townsend K, Lee WT, Laube L, Jolly DJ, Chang SM, Warner JF.
    J Virol; 1993 Jun 15; 67(6):3409-17. PubMed ID: 8497058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.